Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK556373PMID: 32352701
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 491833-29-5
Drug Levels and Effects
Summary of Use during Lactation
Because there is no published experience with eliglustat during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Balwani M, Burrow TA, Charrow J, et al. Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States. Mol Genet Metab. 2016;117:95–103. [PubMed: 26387627]
Substance Identification
Substance Name
Eliglustat
CAS Registry Number
491833-29-5
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Tasimelteon.[Drugs and Lactation Database (...]Review Tasimelteon.. Drugs and Lactation Database (LactMed®). 2006
- Review Lovastatin.[Drugs and Lactation Database (...]Review Lovastatin.. Drugs and Lactation Database (LactMed®). 2006
- Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain.[J Lipid Res. 2012]Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain.Larsen SD, Wilson MW, Abe A, Shu L, George CH, Kirchhoff P, Showalter HD, Xiang J, Keep RF, Shayman JA. J Lipid Res. 2012 Feb; 53(2):282-91. Epub 2011 Nov 4.
- Synthesis, Antibacterial and Lipoxygenase Inhibition Studies of N-(Alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methylbenzenesulfonamides.[Turk J Pharm Sci. 2017]Synthesis, Antibacterial and Lipoxygenase Inhibition Studies of N-(Alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-methylbenzenesulfonamides.Abbasi MA, Rehman AU, Siddiqui SZ, Sheeza A, Nazir S, Ahmad I, Malik R, Aa Shah S. Turk J Pharm Sci. 2017 Apr; 14(1):49-55. Epub 2017 Apr 15.
- Review Lefamulin.[Drugs and Lactation Database (...]Review Lefamulin.. Drugs and Lactation Database (LactMed®). 2006
- Eliglustat - Drugs and Lactation Database (LactMed®)Eliglustat - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...